DoseFlow - Medication Tracker icon

DoseFlow - Medication Trackerv2.1

Released March 4, 2026Major

iOS

What changed

  • PlatformAdded Home Screen widget for progress and dose tracking
  • UXComplete overhaul of Dark Mode for better contrast and transitions
  • New featureIntroduced built-in medication database for easier entry
  • New featureNew dedicated screen for managing active medications and stock levels
  • UXRedesigned medication detail screen with animated progress and charts
  • New featureRevamped history view with full calendar and retroactive logging
  • PerformanceGeneral bug fixes and performance improvements

Original release notes

Your biggest update yet! DoseFlow v2.1 brings a brand-new look and powerful features:

HOME SCREEN WIDGET — Check your daily progress and next dose right from your Home Screen without opening the app.
DARK MODE REFINED — Complete dark mode overhaul across every screen. Smooth transitions, proper contrast, and easy on the eyes at night.
MEDICATION DATABASE — Browse and search from a built-in list of medications when adding new ones. No more typing everything manually.
MY MEDICATIONS — A dedicated screen to view, edit, and manage all your active medications at a glance with stock levels and daily progress.
MEDICATION DETAIL — Completely redesigned detail screen with animated progress ring, weekly activity chart, stock tracking, and schedule info — all in one beautiful card-based layout.
HISTORY REVAMP — Full calendar view with day-by-day dose history. Tap any past date to mark doses as taken retroactively.
Bug fixes and performance improvements throughout.

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by DoseFlow - Medication Tracker, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0